Navigation Links
Penicillin Prevents Return of Leg Infection Called Cellulitis: Study
Date:5/1/2013

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, May 1 (HealthDay News) -- For people who have suffered from cellulitis of the leg, a long course of low-dose penicillin prevents the painful infection from returning, British researchers report.

Once the penicillin is stopped, however, its protective effect diminishes and the condition can flare up again, the researchers noted.

"Low-dose penicillin substantially reduces the risk of further episodes of leg cellulitis in those who have had two or more previous episodes," said lead researcher Hywel Williams, a professor of dermato-epidemiology at the University of Nottingham.

"The penicillin reduced recurrences from 37 percent in the group taking placebo to 22 percent in those taking penicillin," Williams said. "But this effect only occurred in the period that folks took the penicillin. When they stopped the 12 months of penicillin, the protective effect wore off."

Cellulitis is a common infection of the skin and deep underlying tissues. The two most common causes are Staphylococcus (staph) bacteria and group A strep. The bacteria enter the body through an injury such as a bruise, burn, surgical cut or wound, as well as through athlete's foot.

Symptoms can include fever and chills, swollen glands or lymph nodes, and a rash with painful, red, tender skin. In addition, the skin may blister and scab over.

The usual treatment is antibiotics, but the condition commonly returns when treatment is stopped.

Doctors and their patients now have reliable information on a possible way of reducing recurrences of this disabling and painful recurrent disease, Williams said.

"We now know for the first time that low-dose penicillin works, but we don't know how long it should be taken for and whether giving long-term antibiotics may cause resistance problems in the community in the long term, or whether it should be given for people with a first episode of cellulitis or just those with two or more previous episodes," he said.

The report was published in the May 2 issue of the New England Journal of Medicine.

One expert doesn't think this treatment is anything new.

"I know keeping you on antibiotics will prevent cellulitis from recurring," said Dr. Michele Green, a dermatologist at Lenox Hill Hospital, in New York City. "The problem is that the protective effect diminishes once drug therapy is stopped.

"This is what I do with older people. I keep them on antibiotics for a longer period of time so that they don't have a problem, but once you take them off they're just as vulnerable as they were before," Green said. "That's just common sense."

In addition, Green worries that keeping people on antibiotics for extended periods helps build the bacteria's resistance to the drug.

For the new study, Williams' team randomly assigned 274 people who had suffered from cellulitis of the leg that had been treated to one year of treatment with low-dose penicillin or placebos.

Over three years of follow-up, people taking penicillin saw a recurrence of cellulitis 626 days after the drug was stopped, compared with 532 days for those in the placebo group, the researchers found.

While on penicillin, 30 people had a recurrence of cellulitis, compared with 51 patients taking the placebo, they found.

More information

To find out more about cellulitis, visit the U.S. National Library of Medicine.

SOURCES: Hywel Williams, Ph.D., professor, dermato-epidemiology, University of Nottingham, England; Michele Green, M.D., dermatologist, Lenox Hill Hospital, New York City; May 2, 2013, New England Journal of Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Economic analysis finds penicillin, not "the pill," may have launched the sexual revolution
2. New drug prevents spread of human prostate cancer cells
3. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
4. Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor
5. Intense light prevents, treats heart attacks
6. Biosynthetic grape-derived compound prevents progression of Alzheimers disease in mice
7. Fatty acid found in fish prevents age-related vision loss: U of A medical research
8. CNIO researchers discover a new therapy that prevents lung cancer growth in mice
9. Pitt: Targeted oxidation-blocker prevents secondary damage after traumatic brain injury
10. Treated Vaginal Ring Prevents HIV in Monkeys
11. A carefully scheduled high-fat diet resets metabolism and prevents obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Penicillin Prevents Return of Leg Infection Called Cellulitis: Study
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/4/2017)... 2017  South Korean-based healthcare product Development Company I.M. ... on Kickstarter. The device will educate the user about ... better efficiency compared to the dated and pricey CPR ... efficacy of the compression for a more informed CPR ... to raise $5,000. ...
Breaking Medicine Technology: